Bollard Group LLC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1556218 BOSTON, MA

Position in ACRS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,283,327

+$664,711 QoQ

Shares Held

431,631

0.0% QoQ

Ownership

0.293%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#37

of 149 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Bollard Group LLC holds $13,256,543 across 4 Biotechnology names. ACRS ranks #2 (17.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECX	Tectonic Therapeutic, Inc.	302,953	$10,415,524
2	ACRS	Aclaris Therapeutics, Inc. This page	431,631	$2,283,327
3	PRME	Prime Medicine, Inc.	151,136	$557,691
4	VRTX	Vertex Pharmaceuticals Inc / Ma	3	$1

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,283,327	431,631	0.0%	Shares	Defined	2026-08-12
2026-03-31	$1,618,616	431,631	-46.3%	Shares	Defined	2026-05-14
2025-12-31	$2,421,379	804,445	-34.4%	Shares	Defined	2026-02-13
2025-09-30	$2,328,404	1,225,476	-9.4%	Shares	Defined	2025-11-14
2025-06-30	$1,920,231	1,352,276	-5.0%	Shares	Defined	2025-08-13
2025-03-31	$2,178,989	1,424,176	—	Shares	Defined	2025-05-15
No filing history on record for this holder in this stock.